Foracort G Synchrobreathe 120Mdi

Foracort G Synchrobreathe 120mdi may interact with other medicines, such as:

• Antihypertensive medicines (e.g., propranolol, atenolol): Beta-blockers may reduce the bronchodilator effect of formoterol and can worsen breathing symptoms. Avoid combination unless clearly advised by your doctor.
• Antidiabetic medicines (e.g., insulin): This medicine may increase blood glucose levels due to the corticosteroid and beta2-agonist components. Regular blood sugar monitoring may be required during treatment.
• Antitubercular medicines (e.g., rifampicin): These medicines may reduce the effectiveness of budesonide by increasing its metabolism. Your doctor may monitor your response to treatment.
• Antiepileptic medicines (e.g., phenytoin, carbamazepine): These medicines may affect the metabolism of budesonide and reduce its anti-inflammatory effect. Dose adjustment may be required.
• Other long-acting beta2-agonists (e.g., salmeterol): Increase the risk of overdose and serious heart-related side effects. Avoid combination unless advised by your doctor.
• CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): These medicines increase budesonide levels and the risk of side effects. Monitoring may be required.
• Diuretics or xanthines (e.g., furosemide, theophylline): These medicines may increase the risk of low potassium levels. Use with caution.
• Anticholinergic medicines (e.g., tiotropium): Combined use with glycopyrrolate may increase anticholinergic side effects such as dry mouth, constipation, blurred vision, and urinary retention.
• Medicines affecting heart rhythm (e.g., amitriptyline, quinidine): Concomitant use may increase the risk of QT prolongation and irregular heartbeat. Monitoring may be required.

Use Foracort G Synchrobreathe 120mdi with caution if you have:

• Heart disease (e.g., arrhythmia, ischemic heart disease): Formoterol may increase heart rate and trigger palpitations or irregular heartbeat. Patients with existing heart conditions may require close monitoring.
• Hypertension (high blood pressure): This medicine may cause mild increases in blood pressure in some patients. Regular monitoring is recommended, especially in uncontrolled cases.
• Diabetes: Budesonide and formoterol may increase blood glucose levels. Blood sugar monitoring may be required during treatment.
• Glaucoma (especially narrow-angle glaucoma): Glycopyrrolate may increase intraocular pressure and worsen symptoms such as eye pain or blurred vision. Avoid contact of the inhaler spray with the eyes.
• Urinary retention or prostate enlargement (e.g., benign prostatic hyperplasia): Glycopyrrolate may reduce bladder emptying and worsen difficulty in passing urine. Inform your doctor if urinary symptoms occur.
• Infections (e.g., tuberculosis, fungal or viral infections): Budesonide may reduce the body’s ability to fight infections. Existing infections should be treated before or monitored during therapy.
• Thyroid disorders (e.g., hyperthyroidism): Formoterol may worsen symptoms such as increased heart rate, tremors, or nervousness. Monitoring may be required.

The schedule for using Foracort G Synchrobreathe 120mdi is determined by your doctor based on your condition and the severity of symptoms. This inhaler is meant for regular use to maintain control of COPD symptoms, so it should be taken consistently at the same time each day. Do not change how often you take this medicine without consulting your doctor.

Using more than prescribed may increase the risk of side effects such as tremors, palpitations, dizziness, dry mouth, or headache. Seek medical advice if overdose is suspected.

If you forget to take a dose, take it as soon as you remember. If it is close to your next scheduled dose, skip the missed one and continue with your regular schedule. Do not take extra doses to make up for a missed one.